Skip to main content
. 2022 Nov 30;12(3):229–237. doi: 10.1159/000528356

Table 3.

Patterns of tumor recurrence

Patients (n = 70)
Number of patients with HCC recurrence, n (%) 21 (30)
Site of recurrence, n (%)
 Intrahepatic recurrence 16 (76.2)
 Extrahepatic recurrence 3 (14.3)
 Both intra- and extrahepatic recurrence 2 (9.5)
Time until recurrence, n
 <1 year 19
 ≥1 year 2
Major treatment for tumor recurrence, n
 Repeat hepatectomy 3
 Radiofrequency ablation 4
 Radiotherapy 7
 Second-line systemic therapy 2
 Systemic therapy + TACE 2
 None 3

HCC, hepatocellular carcinoma; TACE, transcatheter arterial chemoembolization.